Steven Cohen’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-73,069
Closed -$1.77M – 4365
2026
Q2
$1.77M Sell
73,069
-376,037
-84% -$6.41M ﹤0.01% 2470
2026
Q1
$6.96M Sell
449,106
-2,762,574
-86% -$45.8M 0.01% 1476
2025
Q4
$60.9M Buy
3,211,680
+340,183
+12% +$4.89M 0.07% 329
2025
Q3
$26.5M Sell
2,871,497
-832,097
-22% -$8.64M 0.04% 455
2025
Q2
$42.2M Buy
3,703,594
+3,485,141
+1,595% +$37.7M 0.08% 280
2025
Q1
$2.6M Sell
218,453
-654,506
-75% -$10.9M 0.01% 1163
2024
Q4
$16.4M Buy
+872,959
New +$20M 0.04% 525
2024
Q2
– Sell
-9,500
Closed -$140K – 2274
2024
Q1
$140K Buy
+9,500
New +$102K ﹤0.01% 1960
2023
Q4
– Sell
-1,114
Closed -$8.76K – 2602
2023
Q3
$8.76K Buy
1,114
+1,107
+15,814% +$10.1K ﹤0.01% 2341
2023
Q2
$67 Sell
7
-9,594
-100% -$97.8K ﹤0.01% 2072
2023
Q1
$85.3K Buy
+9,601
New +$100K ﹤0.01% 1662
2022
Q2
– Sell
-69,850
Closed -$979K – 1559
2022
Q1
$979K Sell
69,850
-66,700
-49% -$1.18M ﹤0.01% 964
2021
Q4
$3.95M Buy
+136,550
New +$4.14M 0.02% 719

Other funds holding NRIX

Steven Cohen's NRIX Position: Q3 2026 in Review

Steven Cohen sold out of Nurix Therapeutics (NRIX) in Q3 2026, closing a stake of 73,069 shares — an estimated $1.77M sold.

Steven Cohen first reported a position in NRIX in Q4 2021 and held it in 13 quarters. The position peaked at $60.9M in Q4 2025. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • Steven Cohen reported no remaining Nurix Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 73,069 Nurix Therapeutics shares in Q3 2026, an estimated $1.77M.
  • Steven Cohen first reported a position in Nurix Therapeutics in Q4 2021 and held it in 13 quarters.
  • Steven Cohen's Nurix Therapeutics position peaked at $60.9M in Q4 2025.
  • 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.